Literature DB >> 32780924

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.

I Stefanaki1, A J Stratigos1, K P Kypreou1, E Evangelou2,3, S Gandini4, P Maisonneuve5, D Polsky6, D Lazovich7, J Newton-Bishop8, P A Kanetsky9, S Puig10, N A Gruis11, P Ghiorzo12,13, C Pellegrini14, A De Nicolo15, G Ribas16, G Guida17, J C Garcia-Borron18, M C Fargnoli14, H Nan19, M T Landi20, J Little21, F Sera22, S Raimondi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32780924      PMCID： PMC8327925          DOI： 10.1111/jdv.16869

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

1.  Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

Authors:  María Gabriela Vallone; Gemma Tell-Marti; Miriam Potrony; Aida Rebollo-Morell; Celia Badenas; Joan Anton Puig-Butille; Pol Gimenez-Xavier; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Pigment Cell Melanoma Res       Date:  2017-10-17       Impact factor: 4.693

2.  High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.

Authors:  D L Duffy; K J Lee; K Jagirdar; A Pflugfelder; M S Stark; E K McMeniman; H P Soyer; R A Sturm
Journal:  Br J Dermatol       Date:  2019-07-17       Impact factor: 9.302

3.  Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes.

Authors:  Anna E Barón; Nancy L Asdigian; Victoria Gonzalez; Jenny Aalborg; Tamara Terzian; Regan A Stiegmann; Enrique C Torchia; Marianne Berwick; Robert P Dellavalle; Joseph G Morelli; Stefan T Mokrohisky; Lori A Crane; Neil F Box
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.

Authors:  Anne E Cust; Chris Goumas; Elizabeth A Holland; Chantelle Agha-Hamilton; Joanne F Aitken; Bruce K Armstrong; Graham G Giles; Richard F Kefford; Helen Schmid; John L Hopper; Graham J Mann; Mark A Jenkins
Journal:  Int J Cancer       Date:  2012-01-30       Impact factor: 7.396

5.  Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.

Authors:  Sara Raimondi; Sara Gandini; Maria Concetta Fargnoli; Vincenzo Bagnardi; Patrick Maisonneuve; Claudia Specchia; Rajiv Kumar; Eduardo Nagore; Jiali Han; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Terry Dwyer; Leigh Blizzard; Ricardo Fernandez-de-Misa; Wojciech Branicki; Tadeusz Debniak; Niels Morling; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; Lynn Cornelius; Tomonori Motokawa; Sumiko Anno; Per Helsing; Terence H Wong; Philippe Autier; José C García-Borrón; Julian Little; Julia Newton-Bishop; Francesco Sera; Fan Liu; Manfred Kayser; Tamar Nijsten
Journal:  BMC Med Res Methodol       Date:  2012-08-03       Impact factor: 4.615

6.  Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development.

Authors:  Veronica A Kinsler; Sayeda Abu-Amero; Peter Budd; Ian J Jackson; Susan M Ring; Kate Northstone; David J Atherton; Neil W Bulstrode; Philip Stanier; Raoul C Hennekam; Neil J Sebire; Gudrun E Moore; Eugene Healy
Journal:  J Invest Dermatol       Date:  2012-05-10       Impact factor: 8.551
  6 in total
  1 in total

Review 1.  The Interplay between Nevi and Melanoma Predisposition Unravels Nevi-Related and Nevi-Resistant Familial Melanoma.

Authors:  Stefania Pellegrini; Lisa Elefanti; Luigi Dall'Olmo; Chiara Menin
Journal:  Genes (Basel)       Date:  2021-07-16       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.